Chine : Un forum sur la décision de reformer ou de persévérer sur les politiques de drogues prédit les résultats de l’UNGASS

Des experts se sont réunis en Chine pour discuter de la politique des drogues et comment des approches alternatives en différents pays peuvent contribuer à un débat intéressent à l’UNGASS 2016. Pour en savoir plus, en anglais, veuillez lire les informations ci-dessous.

Abonnez-vous à l'Alerte mensuelle de l'IDPC pour recevoir des informations relatives à la politique des drogues.

On Friday October 23, the Brookings-Tsinghua Center for Public Policy "Reform or Perseverance" panel discussion took place in Beijing, for experts to discuss findings from a recent evaluation into the effectiveness and costs of international drugs policy, ahead of next year's UN meeting on the "World Drug Problem" (UNGASS 2016).

At the discussion experts discussed drugs policy, and how different approaches in different countries might lead to debate at the upcoming meeting. China's drug trade is unique because of its proximity to large-scale drug producing countries, its low rates of violent crime, and because it has one of the highest rates of female participation in the world.

The event, hosted by the center's fellow Liu Zhilin, provided lead researchers from the Brookings Institute and the Transnational Institute the opportunity to give short overviews of case studies in Latin America, Afghanistan, Thailand, and Myanmar as well as a background of previous world drug policy decisions to better understand the current situation in China and probable areas of discussion at UNGASS 2016.

According to "The Chinese Heroin Trade: Cross-Border Drug Trafficking in Southeast Asia and Beyond", authored by Ko-lin Chin and Sheldon X. Zhang, who also managed this year's Brookings Institution case study on China, although in other countries women have been traditionally excluded from drug trafficking, in China women have unexpected rates of participation in the transnational trade, constituting up to a third of traffickers.

Click here to read the full article.

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.

Thumbnail: UN Photo/Eskinder Debebe